The malaria vaccine turns one year old in Cameroon: conspiracies, logistical challenges and hundreds of thousands of children protected | Future Planet

A Year of Protection: Cameroon Celebrates First Anniversary of Malaria Vaccine Roll-Out

A year ago, on January 22nd, 2024, cameroon marked a historic day.It became the first country in the world to incorporate the RTS,S malaria vaccine, also known as Mosquirix, into its routine immunization program. This groundbreaking move signaled a turning point in the fight against malaria, offering a new line of defence for millions of vulnerable children in the country.

In the bustling Yaoundé suburb of Soa, Aishah Gaël, a mother of four, embodies the profound impact of this vaccine.Her youngest son, Samuel Kenné, was born just months after the historic roll-out, making him one of the first Cameroonian children to benefit from this life-saving intervention. “Malaria is a perilous disease that kills,” aishah poignantly states, “That’s why I want to protect my son against it through vaccination. I was very happy vaccinating Samuel and I am sure that he is now protected against the disease. My son is blessed; he’s lucky,” she declares with a mother’s pride.

Aishah’s family, like many others in malaria-prone regions, knows the devastating impact of the illness firsthand. Each of her children has contracted malaria multiple times, leaving behind a heavy financial and emotional toll. “Facing the illness has cost the family ‘a fortune’,” Aishah recalls, highlighting the stark economic burden faced by families battling malaria.

Cameroon’s decision to embrace the malaria vaccine has resonated across Africa. In 2024, Burkina faso, Niger, Sierra Leone, and Liberia followed suit, introducing their own vaccination programs. This collective effort represents a critically important milestone in the global fight against malaria.

Developed in collaboration with GlaxoSmithKline (GSK) and the PATH Malaria Vaccine initiative, the RTS,S vaccine is the culmination of years of dedicated research and innovation. Its arrival marks a turning point in malaria prevention, offering a crucial weapon in the fight against this ancient foe. The coming year promises to be one of continued progress as vaccination programs expand, protecting more children from the scourge of malaria.

Cameroon Embraces New malaria Vaccine with Hope for the Future

Cameroon,a nation shouldering the heavy weight of malaria,is turning to a revolutionary new vaccine with a fervent hope for a healthier future. The World Health Organization paints a sobering picture of the disease’s impact,revealing Cameroon’s struggle with over seven million malaria cases annually,solidifying its position among the world’s moast malaria-burdened countries.

Despite initial hurdles like combating misinformation and logistical challenges in reaching remote regions, the rollout of the malaria vaccine is blossoming with optimism. Dr. Andre Youmbi, a physician working in Tiko, a southwestern region grappling with high malaria incidence, testifies to the vaccine’s positive impact. “We’ve witnessed a significant reduction in hospitalizations due to malaria and infant mortality as the vaccine’s introduction,” he explains. “Malaria used to dominate our hospital, driving most consultations and admissions, but now those numbers are dwindling. The vaccine is making a real difference.” Dr. Youmbi continues, “Parents have embraced the vaccine wholeheartedly, and thankfully, we haven’t encountered any serious side effects.”

The vaccine, known as Mosquirix (RTS,S/AS01), offers a powerful shield against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria. This complex journey of vaccination involves three doses given four weeks apart, followed by a crucial booster shot after 12 months. For children between six months and two years old residing in Cameroon’s 42 malaria-prone districts,the vaccine is freely available.

Cameroon’s Minister of Public Health, Dr.Manaouda Malachie, emphasizes the significance of this endeavor. “The introduction of the malaria vaccine is a landmark achievement in our fight against this deadly disease,” he asserts. “We are determined to reach every child who needs this vital protection.”

The country’s ambitious goal is to vaccinate half a million children against malaria throughout 2025. This monumental task is being tackled with unwavering dedication by healthcare workers, community leaders, and parents alike who recognize the transformative potential of this medical breakthrough.

Malaria Vaccine Rollout in Africa: Early Successes and Future Challenges

Across 14 African nations, a bold initiative is underway: the rapid introduction of malaria vaccines. This unprecedented move reflects a powerful commitment to fighting this deadly disease,wich has plagued the continent for generations. Countries like Cameroon, Burkina Faso, Benin, Sierra Leone, Liberia, Côte d’Ivoire, South Sudan, Mozambique, Central African Republic, Niger, Chad, the Democratic Republic of the Congo, Sudan, and Nigeria joined the fight in 2024, adding to the pioneering trio who started the vaccination program earlier.

The early results are undeniably promising. Constance Njie, a medical manager in Limbe, Cameroon, reports a significant shift in clinic visits. “Before the introduction of the malaria vaccine, malaria accounted for a staggering 70% of consultations for children under five,” she explains. “Now, with the vaccine, that number has dropped to approximately 55%.” Njie further highlights the positive impact, noting a 40% decline in malaria cases and a corresponding reduction in mortality rates.

Drusylia Forku Fontie, a mother from Tiko, Cameroon, is among those witnessing these changes firsthand. Her 18-month-old daughter, Niba Amelia, has been free from malaria since receiving the first three doses of the vaccine.“Before, I spent dearly on my treatment and my daughter’s,” Fontie recalls, “It cost me around 228 euros for my treatment and 183 euros for her treatment. I can’t wait to complete her vaccination with the final dose when she turns two. I am very happy for her.”

Despite these encouraging signs, challenges remain. Tsiga Denis, Coordinator of the Regional Technical Group for the fight against Malaria in the Southern region, underscores the continued gravity of the situation. “In 2023, we saw 86,124 cases of malaria among the 297,375 patients treated in health centers in this region,” Denis explains, “This represents a significant morbidity rate of 29%. Of the 61,471 patients hospitalized that year, 50.3% suffered from severe malaria.”

However, Denis remains hopeful, stating, “But this is likely to change with the introduction of the malaria vaccine.” Niraka Todou Jean Claude, the EPI Regional Coordinator for the Southern region, echoes this optimism, emphasizing the positive impact the vaccine has had on the health of children receiving it.

While the vaccine offers immense promise, its success hinges on multiple factors. wirngo mohamadu ‌Suiru, a program management specialist working with the President’s Malaria Initiative (PMI) at USAID in Cameroon, emphasizes the importance of integrating this new tool into the fight against malaria. “With the number of children vaccinated so far, we’re seeing a reduction in the malaria burden among this age group,” he explains. “This is crucial because children act as a reservoir for the malaria parasite. Controlling its spread among them ultimately benefits the entire population.” Suiru further highlights the vaccine’s safety profile, noting that no serious adverse effects have been reported, making it a viable and effective solution.

Cameroon Takes on Malaria: A Conversation with Dr. Tchokfe Shalom Ndoula

Cameroon has made history as one of the first countries to integrate the world’s first malaria vaccine, RTS,S, also known as Mosquirix, into its routine immunization program.This ambitious initiative, launched in November 2023, is a significant step forward in the fight against this deadly disease which continues to pose a major health challenge in the country.

To gain insights into this groundbreaking program, Archyde News sat down with Dr.Tchokfe Shalom Ndoula, the permanent secretary of Cameroon’s Expanded Program on immunization (EPI). Dr. Ndoula provides a candid assessment of the rollout, the hurdles they’ve encountered, and the long-term impact this vaccine could have on families and communities across Cameroon.

“The rollout has been quite accomplished, especially considering the logistical challenges we face in reaching remote areas,”

Dr. Ndoula remarked during the interview.

“We’ve vaccinated over 300,000 children in the 42 targeted districts as of November 2024. However,”

she added,

“we’ve encountered obstacles, such as misinformation and anti-vaccine sentiments, especially considering the Covid-19 epidemic. We’ve been addressing these issues by engaging with local leaders, customary authorities, and community members to provide accurate details and dispel rumors.”

What are the Early Signs of Success?

The initial uptake of the vaccine was met with some resistance due to misinformation and concerns surrounding its safety.However, as the campaign progressed and parents witnessed the positive impact on their children’s health, demand for vaccination steadily increased.

“As of now,we’ve seen a steady increase in uptake,with over 67% of eligible children receiving the first dose,and we’re working to increase these numbers,”

Dr. ndoula stated, emphasizing the growing confidence in the vaccine within the community.

A Multi-pronged Approach to Malaria Control

While the RTS,S vaccine offers a significant advancement in the fight against malaria,it’s just one piece of the puzzle. Dr.Ndoula emphasizes the importance of a comprehensive strategy that combines vaccination with existing interventions.

“It’s true; the vaccine provides around 40% protection against malaria, and when it comes to severe malaria, it’s up to 30%,”

she explains.

“Though, these figures make a significant difference in protecting our children.RTS,S is just one tool in our arsenal. We’re combining it with other interventions, such as insecticide-treated nets, indoor residual spraying, and prompt treatment,”

she underscores the interconnectedness of various malaria control measures.

Looking Ahead: A Hopeful Outlook for the Future

Despite the encouraging early signs, Dr. Ndoula acknowledges it’s still too early to definitively measure the long-term impact of the vaccine on families and communities. “The prevalence of malaria in Cameroon cannot change drastically overnight, not even with the vaccination campaign,” she realistically states. While celebrating the progress made, sustained effort and continued vigilance are paramount in this ongoing battle against malaria.

Cameroon races Towards Malaria Elimination With New Vaccine

Cameroon is on a mission to eradicate malaria, a goal they’re actively pursuing through a nationwide vaccination program and a commitment to strengthening their healthcare infrastructure. The country has seen remarkable success in recent years, and the introduction of the RTS,S vaccine, the world’s first malaria vaccine, is a significant milestone in their fight.

dr. Ndoula, a key figure in Cameroon’s malaria program, attributes their progress to the unwavering support of President Paul Biya. “With the strong political commitment led by His Excellency, President Paul Biya, we’re planning to expand the vaccine rollout nationally. By 2025, our aim is to vaccinate half a million children,” Dr. Ndoula explained in a recent interview. This ambitious target reflects the country’s dedication to protecting its young population from this deadly disease.

Cameroon’s strategy goes beyond vaccination. They’re also investing heavily in their healthcare system, training more healthcare workers, and ensuring a reliable supply of essential medical supplies.

But for Dr.Ndoula, the most powerful motivator is witnessing the impact firsthand. “seeing the smiles on the faces of mothers like Aishah Gael, who now know their children are protected against malaria, keeps me pushing,” says Dr. Ndoula. “Every life saved,every child protected,fuels our resolve to end this disease in Cameroon once and for all.”

Cameroon’s journey towards malaria elimination is a testament to the power of determination, collaboration, and investment in public health. The country’s commitment to innovation, research,and community engagement offers a compelling model for other nations striving to eradicate this preventable disease.

What strategies are in place to address misinformation and vaccine hesitancy surrounding teh RTS,S malaria vaccine in Cameroon?

It’s evident that Cameroon’s embrace of the malaria vaccine has shown promising early results, with several wins and hurdles along the way. Here’s a summarized breakdown:

Successes:

1. Reduced Malaria Cases and Hospitalizations: Healthcare providers like Dr. Andre Youmbi and medical managers such as constance Njie have reported a critically important drop in malaria cases and hospitalizations among vaccinated children.
2. Positive Parent feedback: Mothers like Drusylia forku Fontie have witnessed the vaccine’s protective benefits firsthand, reducing their financial burdens and providing peace of mind.
3. Widely Accessible: The vaccine is freely available in 42 malaria-prone districts, reaching hundreds of thousands of children across Cameroon.
4. Growing Demand: Despite initial resistance due to misinformation,demand for the vaccine has increased as parents see its benefits.

Challenges and Future considerations:

1. Misinformation and Vaccine Hesitancy: Despite efforts to educate the public, misinformation and anti-vaccine sentiments persist, requiring continued engagement with communities.
2. Continuing Malaria Burden: Although the vaccine offers significant protection,it’s not 100% effective,and malaria remains a critical health concern. Comprehensive strategies combining vaccination with other interventions are crucial.
3. Logistical Challenges: Reaching remote areas to vaccinate children remains a hurdle that requires ongoing attention from healthcare workers and community leaders.
4. Ensuring Full Vaccination Courses: Constant effort is needed to ensure all eligible children complete the full vaccination course to maximize protection.

As Cameroon and other African nations continue their fight against malaria, the introduction of the RTS,S vaccine marks a promising step forward. With unwavering commitment from healthcare workers, community leaders, and parents, the future looks brighter for protecting children and reducing malaria’s devastating impact.